Clinical classification of age-related macular degeneration.
about
Choroidal Haller's and Sattler's layer thickness measurement using 3-dimensional 1060-nm optical coherence tomographyCellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for ProteoglycansRelationship between Oxidative Stress, Circadian Rhythms, and AMDGeographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospectsAlternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injuryClinical applications of fundus autofluorescence in retinal diseaseChoroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyesThe Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular DegenerationA view of the current and future role of optical coherence tomography in the management of age-related macular degeneration.Cone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration.Present and possible therapies for age-related macular degeneration.Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE studySmoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation.Magnetic nanoparticles conjugated with "RPE cell -MCP-1 antibody -VEGF antibody" compounds for the targeted therapy of age-related macular degeneration: a hypothesisReticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization.A Review of Current and Future Management of Geographic Atrophy.Cholesterol in the retina: the best is yet to come.Evaluation of Two Systems for Fundus-Controlled Scotopic and Mesopic Perimetry in Eye with Age-Related Macular Degeneration.ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.Studying age-related macular degeneration using animal models.Early signs of exudative age-related macular degeneration in AsiansClinical applications of age-related macular degeneration genetics.Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.Age-related macular degeneration: genetics and biology coming together.Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging[Reticular drusen over time with SD-OCT].CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization.Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft Drusen in vivo using adaptive optics imaging.Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study.Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case-control study.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.Choroidal thickness in patients with reticular pseudodrusen using 3D 1060-nm OCT maps.Photoreceptor perturbation around subretinal drusenoid deposits as revealed by adaptive optics scanning laser ophthalmoscopy.The ophthalmic branch of the Gutenberg Health Study: study design, cohort profile and self-reported diseasesVision from next generation sequencing: multi-dimensional genome-wide analysis for producing gene regulatory networks underlying retinal development, aging and diseaseSmall Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study.Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine learning approachIn-vivo mapping of drusen by fundus autofluorescence and spectral-domain optical coherence tomography imaging.Inflammatory Mechanisms of Age-related Macular Degeneration.
P2860
Q21090612-8F06E0F4-AD17-447F-BB79-6533F374903EQ26738776-F1AD7148-ECAE-4EE2-B37D-E91E977412ADQ26765278-466DC73F-F37C-4FE5-A8F2-1EF32AC9742BQ26774188-3C8FE30D-7F15-4D7B-A848-20A73C166878Q27311630-60CA0933-979E-4CBA-8052-F336B000027BQ28075181-6087B668-31F4-47A0-9B9A-FE809B7F11F7Q28244515-FC31CBD8-AE44-40C3-A933-056081D5DF22Q28645952-8E476663-F9CA-4271-8FF3-C0F200EEFEA7Q30240689-F6A9EEB8-12CF-4EB1-B6C3-2F342C2F5714Q30557413-501ABE46-AEB9-4122-9401-E0033473241AQ33562731-91A8F42C-A30B-4834-8944-E7901571C2F4Q33586908-EBA8AFF5-1769-4131-A422-458C9391DA4CQ33652041-F09F9B3C-7FA8-43FB-BFF2-B0F40B5317C1Q33706139-3831F0C2-6B87-49E2-BBF3-535CED91A387Q33717512-5A7FA9D3-4501-4482-BC32-74EC1012624EQ33740158-15C47E23-C112-43AF-934B-5995A9DC90ABQ33758267-1FB14E36-5DA3-4E4D-8426-1C7DD6EDCD6AQ33902391-7C31678B-AB23-4A41-BFE9-FF2461F4E472Q34109426-E28755EC-B54C-4ED7-A7B3-FA785F23266EQ34293850-1D1066CE-88AB-498E-864B-EFFB303B9FEEQ34293886-95D27BA2-B0A1-46BF-A9BC-58B9EF3126CAQ34355357-4FE5CF1E-8147-4296-88C8-4C30BA376B37Q34395891-73492232-236B-49F2-904E-69F44A6656B4Q34440797-9B143B22-40CB-4251-91DB-3FEEC913EF2CQ34444212-191853E7-0B6E-46EB-BED1-2C4E44570D8DQ34575838-193FC982-DF67-4DD9-9FF3-2874552EB300Q35013968-C86A1D64-E579-4228-A47F-92DAC68C9F5AQ35028401-B905E2F9-FC8B-42A7-8B79-9D9EBA9DCD2CQ35030732-D47EB2D3-5C18-4048-8576-4AEA83C8D1AFQ35079376-2EC9727E-366B-4462-A231-29FBD06CD1B6Q35103889-EB1146D8-EF11-474E-A16C-DF5662C03907Q35118257-5F732E07-AFFC-4A71-A8F7-3C44040BB336Q35126496-DF483F97-EA26-4065-9721-EF6E3FCD1304Q35174975-1ACC9FF5-76F4-4273-8264-D29AA0B638F9Q35182480-2A382923-54E5-49AB-A6EB-B9B742645165Q35470460-A6086751-7E98-4D85-80AB-A475B1F88D75Q35482225-324F937B-7B23-4AFC-8E71-A14F1B15403DQ35549563-36DE5BEB-F5F8-4036-B1C8-1572BB51712DQ35612233-E80F2420-CED3-4031-AE3B-C62B65323EAFQ35755942-954F3B64-8C70-426E-A5FD-18052FE442F3
P2860
Clinical classification of age-related macular degeneration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical classification of age-related macular degeneration.
@en
type
label
Clinical classification of age-related macular degeneration.
@en
prefLabel
Clinical classification of age-related macular degeneration.
@en
P2093
P1433
P1476
Clinical classification of age-related macular degeneration.
@en
P2093
Beckman Initiative for Macular Research Classification Committee
C P Wilkinson
Frederick L Ferris
Karl Csaky
SriniVas R Sadda
Usha Chakravarthy
P304
P356
10.1016/J.OPHTHA.2012.10.036
P50
P577
2013-01-16T00:00:00Z